TBPH Theravance Biopharma Inc Gross Profit Rate

Official company branding of Theravance (TBPH)

Strategic alliances with industry behemoths to bring respiratory products to market establish the foundation for growth at Theravance Biopharma (TBPH). The gross sales margin illustrates production efficiency, while the 94.40 metric indicates profitability status. This model provides resilience against economic downturns, and stable demand for inhalation drugs guarantees a reliable stream of royalties from partners.

theravance.com (TBPH) Return on Gross Profit: for the period 07/04/2022 - 10/10/2026

Analytical breakdowns and data insights for company Theravance Biopharma, Inc. (TBPH)

- stock value and consensus price forecast:
- cash balance and cash flow data:
Fundamental valuation:TBPH, Theravance Biopharma, Inc.
Manufactured product of theravance.com

Gross margin measures the efficiency of direct production, determining the profit share after deducting all variable costs associated with product creation. The current value of 94.40, represented by the average gross margin, confirms the high profitability of Theravance Biopharma (TBPH), which is sustained by the planned capacity utilization of respiratory complexes and the continuous technological upgrading of sterile lines to comply with stringent industry standards.

Direct competitors

Gross Profit Margin Haleon PLC (HLN)|Return on Gross Profit KVUE|Gross Profit Margin Verona Pharma Inc. VRNA|Gross Margin MENS|Ligand Pharmaceuticals - Gross Return on Sales|Gross Profitability Amneal AMRX|Gross Sales Margin Perrigo Company PLC|Alvotech Biopharmaceuticals - Gross Margin|Return on Sales by Gross Profit Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Gross Profitability|anipharmaceuticals.com - Gross Profit Rate|Return on Gross Profit MNKD|AMPH: Gross Profit Rate|Gross Profitability pacira.com (PCRX)|Gross Margin ARS Pharma (SPRY)|Aquestive Pharma - Return on Gross Profit|Gross Margin scpharmaceuticals.com SCPH|Tectonic - Gross Margin|TNXP - Gross Margin|SXTC: Gross Margin|Eupraxia Pharma - Gross Profit Rate|BHST (bioharvest.com) - Gross Margin|Gross Return on Sales EXOZ (invizyne.com)|Gross Margin ORMP|Return on Sales by Gross Profit Entera Bio|Gross Margin HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Gross Profitability|Cumberland Corp - Gross Margin|QNTM - Gross Margin|FibroGen, Inc. (FGEN) - Gross Profitability|TELO: Gross Profit Ratio|RANI (Rani Therapeutics Inc) - Gross Margin|Gross Profit Margin synergychc.com SNYR|Gross Profitability Rallybio Corp. (RLYB)|LEXX - Gross Profit Margin|Gross Margin PULM (pulmatrix.com)|Gross Profit Ratio PTHL (Pheton)|APM - Gross Profitability|Return on Sales by Gross Profit Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Gross Profitability|TNF Pharma (TNFA) - Gross Margin|YCBD (cbdmd.com) - Gross Margin|Return on Gross Profit PainReform (PRFX)|Gross Profitability Altamira Therapeutics (CYTO)|Return on Sales by Gross Profit Lipella Pharma|Optinose - Return on Gross Profit|Return on Sales by Gross Profit pieris.com (PIRS)|PROC - Gross Profitability|Gross Profitability Margin PTPI|QLI: Gross Margin|Gross Profit Margin ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Gross Margin